| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 10/24/2006 | US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals |
| 10/24/2006 | US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 10/24/2006 | US7125886 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
| 10/24/2006 | US7125854 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 10/24/2006 | CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 10/24/2006 | CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives |
| 10/24/2006 | CA2259031C Androgen receptor modulator compounds and methods |
| 10/24/2006 | CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators |
| 10/24/2006 | CA2222517C Agents for use against parasitic protozoa |
| 10/24/2006 | CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 10/19/2006 | WO2006110654A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 10/19/2006 | WO2006109085A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | WO2006108562A1 Manufacture of lactones |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235060 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/19/2006 | US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration |
| 10/19/2006 | US20060234983 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 10/19/2006 | US20060234904 Method for preparing polymorphism of irinotecan hydrochloride |
| 10/19/2006 | US20060234349 Fungal cell wall synthesis gene |
| 10/19/2006 | US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 10/19/2006 | US20060234143 Combining a substituted or unsubstituted indoline with a substituted or unsubstituted 3',6-dichlorofluoran;isolating substituted or unsubstituted 3'-chloro-6'-indolinofluoran combining substituted with a substituted or unsubstituted aniline |
| 10/19/2006 | CA2853635A1 Spiro-oxindole compounds and their uses as therapeutic agents |
| 10/19/2006 | CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | CA2604010A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 10/18/2006 | EP1712230A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 10/18/2006 | EP1711809A2 Time-temperature indicator based on valence isomerizations |
| 10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
| 10/18/2006 | EP1711494A1 Aryl substituted heterocycles, method for production and use thereof as medicaments |
| 10/18/2006 | EP1534255A4 Processes for preparing 1,3-dioxolane nucleosides |
| 10/18/2006 | CN1847246A Galantamine derivative and its prepn process and use |
| 10/18/2006 | CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 10/18/2006 | CN1280272C Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/18/2006 | CN1280258C Process for producing 4,5-diamino shikimic acid derivative |
| 10/17/2006 | USRE39356 Macrolactamization; deesterification, coupling decyclization, catalysis; one pot process; anticarcinogenic and antiproliferative agents |
| 10/17/2006 | US7122679 Multicyclic compounds and the use thereof |
| 10/17/2006 | US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents |
| 10/17/2006 | US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 10/17/2006 | US7122553 Liposomal formulation of irinotecan |
| 10/17/2006 | US7122545 Imidazo-benzothiazoles |
| 10/17/2006 | US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 10/17/2006 | US7122526 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 10/17/2006 | US7122189 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 10/17/2006 | US7122081 Reducing particle size of organic pigments by milling the crude pigment in the presence of a water soluble styrene copolymer dispersant, optionally a defoamer, optionally an additive, and greater than about 10 wt. % water, and isolating the organic pigment |
| 10/17/2006 | CA2318527C Inhibitors of .alpha.4 mediated cell adhesion |
| 10/17/2006 | CA2284976C Process for preparing single enantiomer narwedine |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/12/2006 | WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/12/2006 | WO2006106136A1 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
| 10/12/2006 | WO2006106135A1 Crystal form of asenapine maleate |
| 10/12/2006 | US20060229359 Tocopherol-modified therapeutic drug compounds |
| 10/12/2006 | US20060229353 Substituted heterocycles |
| 10/12/2006 | US20060229352 asenapine synthesis, a schizophrenia drug |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 10/12/2006 | US20060228557 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 10/12/2006 | CA2603509A1 Crystal form of asenapine maleate |
| 10/12/2006 | CA2603181A1 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
| 10/12/2006 | CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/11/2006 | EP1710245A1 Crystal form of asenapine maleate |
| 10/11/2006 | EP1710241A1 Intermediate compounds for the prepation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
| 10/11/2006 | EP1709047A2 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 10/11/2006 | EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 10/11/2006 | EP1709004A2 Pyrrole and pyrazole daao inhibitors |
| 10/11/2006 | CN1845925A Substituted heterocycles |
| 10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 10/11/2006 | CN1279039C Hetaryl substituted homotetramic and homotetramic acids and the use thereof as pesticides |
| 10/10/2006 | US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists) |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 10/10/2006 | US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
| 10/10/2006 | US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders |
| 10/10/2006 | CA2359046C Heterocyclically anellated indenochromene derivatives |
| 10/10/2006 | CA2237056C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 10/10/2006 | CA2211889C Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines |
| 10/10/2006 | CA2150804C Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives |
| 10/05/2006 | WO2006104897A2 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | WO2006104406A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | WO2006103255A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | WO2006091800A3 Novel pyridine derivatives as potassium ion channel openers |
| 10/05/2006 | WO2006048248A3 Novel anthranilamide pyridinureas as vegf receptor kinase imhibitors |
| 10/05/2006 | US20060223844 Mitotic kinesin inhibitors |
| 10/05/2006 | US20060223839 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno-[3,4-f]-quinolines as selective progesterone receptor modulator compounds |
| 10/05/2006 | US20060223832 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | CA2603088A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | CA2602574A1 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | CA2602284A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | CA2585333A1 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 10/04/2006 | EP1707568A2 A pharmaceutical composition for use in the treatment of ovarian cancer in a human afflicted therewith |
| 10/04/2006 | EP1706412A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 10/04/2006 | EP1706409A1 Compounds useful in therapy |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |